Tags : Promotion

Exact Sciences and Pfizer Announce Extension and Amendment of their

Vartika Singh October 7, 2020

Shots: Pfizer will continue to provide sales and marketing support and health system support for Cologuard through the end of 2022 and 2021, respectively. Exact Sciences will compensate Pfizer based on the amount of services provided, along with additional fixed and performance-related fees set forth in the agreement Cologuard was approved by US FDA in […]Read More

Pharma

AstraZeneca Signs an Exclusive Promotion Agreement with Luye Pharma for

Vartika Singh January 17, 2019

Shots: AstraZeneca to get exclusive promotion rights in China including Taiwan, Hong Kong, Singapore, Malaysia for Luye’s Xuezhikang capsules. Luye Pharma will retain its IPR, commercialization rights, asset rights & registration permit rights The focus of the agreement is to promote Xuezhikang in cardiovascular disorders and strengthening Luye’s footprints in cardiology, with its further expansion […]Read More

Claritas Collaborates with CMAX to Initiate P-I Study of R-107 for Pulmonary Arterial Hypertension

Vertex Amend its Collaboration with CRISPR Therapeutics for Development and Commercialization of CTX001 in SCD and Beta Thalassemia

Spark Therapeutics Signs an Option Agreement with Senti Bio to Develop Precision Gene Therapies

BMS and PsiOxus Therapeutics Expand their 2016 Immuno-Oncology Collaboration

Prestige Biopharma and Pharmapark Sign an Exclusive License and Supply Agreement to Commercialize HD204 (biosimilar, bevacizumab) in Russia

PlantForm Signs Research and Development Agreement with Bio-Manguinhos/Fiocruz to Develop Biosimilar Pembrolizumab

Johnson & Johnson Publishes Results of COVID-19 Single Shot Vaccine in NEJM

J&J Pauses Dosing of COVID-19 Vaccine Due to Blood Clotting

LEXEO Therapeutics Receives the US FDA’s Fast Track Designation for LX1001 to Treat APOE4 Associated Alzheimer Disease

GW Pharmaceuticals’ Epidyolex (cannabidiol) Receives EC’s Approval for the Treatment of Seizures Associated with Tuberous Sclerosis Complex

AgeneBio Reports Completion of Patient Enrollment in P-IIB HOPE4MCI Trial for AGB101 to Treat Amnestic Mild Cognitive Impairment due to Alzheimer Disease

TG Therapeutics Initiates Patient Enrolment in P-III ULTRA-V Trial for Triple Combination Regimen to Treat R/R Chronic Lymphocytic Leukemia

Tags : Promotion

Exact Sciences and Pfizer Announce Extension and Amendment of their

AstraZeneca Signs an Exclusive Promotion Agreement with Luye Pharma for

Latest Posts

Claritas Collaborates with CMAX to Initiate P-I Study of R-107 for Pulmonary Arterial Hypertension

Johnson & Johnson Publishes Results of COVID-19 Single Shot Vaccine in NEJM

AgeneBio Reports Completion of Patient Enrollment in P-IIB HOPE4MCI Trial for AGB101 to Treat Amnestic Mild Cognitive Impairment due to Alzheimer Disease

TG Therapeutics Initiates Patient Enrolment in P-III ULTRA-V Trial for Triple Combination Regimen to Treat R/R Chronic Lymphocytic Leukemia

Tags : Promotion

Latest Posts

Categories

Related Topics